@prefix this: . @prefix sub: . @prefix beldoc: . @prefix rdfs: . @prefix rdf: . @prefix xsd: . @prefix dct: . @prefix dce: . @prefix pav: . @prefix np: . @prefix belv: . @prefix prov: . @prefix schem: . @prefix chebi: . @prefix go: . @prefix Protein: . @prefix sfam: . @prefix geneProductOf: . @prefix hasAgent: . @prefix obo: . @prefix occursIn: . @prefix species: . @prefix pubmed: . @prefix orcid: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { sub:_1 hasAgent: sub:_2; a go:0016301 . sub:_2 geneProductOf: sfam:AKT%20Family; a Protein: . sub:_3 rdf:object sub:_1; rdf:predicate belv:increases; rdf:subject chebi:18723; a rdf:Statement . sub:_4 occursIn: obo:CL_0002328, species:9606; rdf:object sub:_3; rdf:predicate belv:decreases; rdf:subject schem:LY%20294002; a rdf:Statement . sub:assertion rdfs:label "a(CHEBI:nicotine) -> kin(p(SFAM:\"AKT Family\"))", "a(SCHEM:\"LY 294002\") -| (a(CHEBI:nicotine) -> kin(p(SFAM:\"AKT Family\")))" . } sub:provenance { beldoc: dce:description "Approximately 61,000 statements."; dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved."; dce:title "BEL Framework Large Corpus Document"; pav:authoredBy sub:_6; pav:version "20131211" . sub:_5 prov:value "To confirm that increased Akt phosphorylation at S473 and T308 was indicative of increased kinase activity, we measured the phosphorylation of an exogenous peptide substrate, glycogen synthase kinase-3?/? (GSK-3?/?), after nicotine or NNK administration (Figure 2a). Nicotine or NNK increased Akt kinase activity in a PI3K-dependent manner, since the PI3K inhibitor LY294002 (18) inhibited induction of Akt activity by nicotine or NNK."; prov:wasQuotedFrom pubmed:12511591 . sub:_6 rdfs:label "Selventa" . sub:assertion prov:hadPrimarySource pubmed:12511591; prov:wasDerivedFrom beldoc:, sub:_5 . } sub:pubinfo { this: dct:created "2014-07-03T14:31:57.807+02:00"^^xsd:dateTime; pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 . }